Cerus

Join the Cerus webinar on clinical and operational perspectives on the mitigation of transfusion-borne infections in Latin America with pathogen inactivation. To register, click here: https://bit.ly/Bio_Wbinr_inactivacion The activity will feature the participation of: -Dr. Otalora from the Universidad del Rosario in Colombia who will provide a comprehensive review of infections

Cerus presenta el webinar "Por qué la inactivación de patógenos es la opción proactiva para mejorar la seguridad y disponibilidad de la sangre: la perspectiva de un patólogo". Disertará en este seminario web María de los Ángeles Muniz, Patóloga del Departamento de Medicina Transfusional del Hospital Universitario Robert Wood Johnson de Estados Unidos. María proporcionará

Coronavirus (COVID-19) has highlighted disturbing elements about the continuity of the health system. Blood availability and patient safety may be compromised, as the risk of transfusion-transmission (TTI) of new pathogens cannot be mitigated by tests that are not yet available. Pathogen inactivation (IP)